Akèy › Kansè (tout kalite) › Kalifòni › San Francisco
Etid klinik pou Kansè (tout kalite) nan San Francisco, CA
35 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
PediRISE Feasibility
Ap rekrite
- University of California San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Ap rekrite
- Kaiser Permanente-San Francisco, San Francisco
Intratumoral N17350 in Advanced Solid Tumors
Ap rekriteFaz 1/2
- University of California, San Francisco, San Francisco
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Ap rekriteFaz 2
- Kaiser Permanente - South San Francisco Medical Center, San Francisco
- California Pacific Medical Center Research Institute, San Francisco
- Kaiser Permanente - San Francisco Medical Center, San Francisco
- ak 1 plis
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Ap rekriteFaz 2/3
- University of California, San Francisco- California, San Francisco
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
Ap rekriteEtid obsèvasyon
- University of California, San Francisco, San Francisco
Prostate Active Surveillance Study
Ap rekriteEtid obsèvasyon
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Ap rekriteFaz 1
- UCSF, San Francisco
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Ap rekriteFaz 1
- UCSF, San Francisco
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- UCSF Medical Center-Mission Bay, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
International Rare Brain Tumor Registry
Ap rekriteEtid obsèvasyon
- University of California San Francisco, San Francisco
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- California Pacific Medical Center-Pacific Campus, San Francisco
- Kaiser Permanente-San Francisco, San Francisco
GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer
Ap rekrite
- Stanford Cancer Institute, San Francisco
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Ap rekriteFaz 2
- The Unviersity of California, San Francisco (UCSF), San Francisco
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ap rekriteFaz 2
- 014, San Francisco
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Ap rekriteFaz 1
- University of California San Francisco, San Francisco
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- UCSF Medical Center at Mission Bay, San Francisco
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Ap rekriteFaz 1/2
- UCSF Medical Center - Mission Bay, San Francisco
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Childhood Cancer Survivor Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- University of California-San Francisco, San Francisco
Multisite Implementation of COMPRENDO
Ap rekriteVolontè an sante akeyi
- University of California San Francisco Benioff Children's Hospitals, San Francisco
Galleri® in the Medicare Population.
Ap rekriteVolontè an sante akeyi
- University of California San Francisco Health System, San Francisco
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- University of California San Francisco (UCSF), San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Ap rekrite
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Ap rekriteFaz 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
Ap rekrite
- University of California, San Francisco, San Francisco
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Ap rekriteFaz 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Primary Tumor Research and Outcomes Network
Ap rekriteEtid obsèvasyon
- UCSF Medical Center, San Francisco
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Ap rekriteEtid obsèvasyon
- University of California San Francisco, San Francisco
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Ap rekriteFaz 2
- University of California, San Francisco, San Francisco
ChangeGradients: Promoting Adolescent Health Behavior Change
Ap rekriteVolontè an sante akeyi
- University of California San Francisco Adolescent and Young Adult Medicine Clinic, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, San Francisco
A Study of NX-1607 in Adults With Advanced Malignancies
Ap rekriteFaz 1
- University of California, San Francisco, San Francisco
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY109 etid
- Boston, MA85 etid
- Los Angeles, CA74 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Washington, DC58 etid
- Durham, NC58 etid
- Chicago, IL51 etid
- Atlanta, GA49 etid
- Seattle, WA49 etid
- Arlington, VA48 etid
Lòt etid nan San Francisco
- Kansè pwostat45 etid
- Kansè nan tete43 etid
- Kansè Poumon ki pa ti selil36 etid
- Ensifizyans kadyak29 etid
- Kansè Metastatik28 etid
- Kansè poumon22 etid
- Melanom22 etid
- Kansè pankreyas20 etid
- Kansè ovè19 etid
- Kansè kolorektal18 etid
- Maladi kadyovaskilè18 etid
- Gliyoblastòm17 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.